During the past decade, Fondazione EMN Italy Onlus conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fondazione EMN Italy Onlus" #1 collaborator was "Fondazione EMN Italy Onlus" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Fondazione EMN Italy Onlus" are "Multiple Myeloma" (3 trials). Many other conditions were trialed in "Fondazione EMN Italy Onlus" in a lesser frequency.

Most popular intervention types in "Fondazione EMN Italy Onlus" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (3 trials), "Dexamethasone" (3 trials), "Carfilzomib" (2 trials) and "Pomalidomide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fondazione EMN Italy Onlus" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Fondazione EMN Italy Onlus". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Fondazione EMN Italy Onlus, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Fondazione EMN Italy Onlus, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".